Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
-
D-Wave’s Qubits 2024 Quantum Computing Conference Announced for June 17-18 in Boston
-
Quantix Acquires Space City Services
-
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024
-
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024
-
CPI Card Group® Announces Expansion with New Production Facility in Fort Wayne, Indiana
-
GeoVera Announces Combination of Its Insurance Carriers with SafePort Insurance Company to Create GeoVera Nova Holdings; Will Simultaneously Sell MGA to SageSure
-
Identiv Highlights Excellence in Specialty IoT Solutions at RFID Journal LIVE! 2024
-
Kaixin Auto Holdings Announces Name Change
-
Altair Wins 2024 Google Cloud North America Partner of the Year Award for Diversity, Equity, and Inclusion
-
Sibros Partners with Harbinger to Revolutionize the Medium-Duty Vehicle Industry
-
Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act
-
ABBYY Helps Nagarro Improve Customers’ Visibility and Reduce Invoice Processing Time by 60%
-
HR Path welcomes Brazilian's leading SAP partner, Intelligenza
-
Virtuosi® Becomes an IACET Accredited Provider
-
Asbury Automotive Group Schedules Release of First Quarter 2024 Financial Results
-
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
-
Darrow Co-Founder And CTO Gila Hayat Named To Inc.'s 2024 Female Founders List
-
Upbound Group, Inc. Announces Timing of First Quarter 2024 Financial Results
-
DataVisor Partners with Mitek to Strengthen Fraud Detection Ecosystem with Enhanced Check Fraud Protection
-
Nvelop Therapeutics Launches with Dual Platforms for In Vivo Delivery of the Next Generation of Genetic Medicines
-
LogRhythm and RedLegg are Now Delivering Cloud-Native SIEM Capabilities to Security Operations Teams
-
Tru Consulting Awarded Anaplan’s Regional Partner of the Year for the Americas
-
More Redemption Options, Everyday Value, and More Choice Headline New Analysis of Credit Card Rewards Programs
-
Edge computing leader J-Squared Technologies announces partnership with software pioneer CVEDIA at ISC West
-
Entrust Completes Acquisition of Onfido, Creating A New Era of Identity-Centric Security
-
Everyware Launches Comprehensive Suite of Identity Verification Solutions to Transform Customer Security
-
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
-
Composable DXP leader Contentstack Announces New Partnership with Google Cloud
-
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting
-
Dude Perfect® and Highmount Capital® Announce Partnership Inclusive of Strategic Growth Capital
-
Hispanic C-Suite Corporate Council Announces Leslie Sanchez, Jorge Ferraez and Ana Mollinedo Mims to the HC3 Board of Directors
-
LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "
-
Bowman Welcomes David Stickles, RPLS, PSM, PLS, to Expand Company’s Public Sector Geospatial Portfolio
-
EVgo Expands Autocharge+ to More Than 50 Electric Vehicle Models
-
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
-
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
-
Wellfit Partners With HFD to Expand Financing Coverage Across the Credit Spectrum
-
Sunoco LP and NuStar Energy L.P. Announce Expiration of Hart-Scott-Rodino Act Waiting Period
-
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
-
Ethic Surpasses $5 Billion in Assets
-
EFISHient Protein Announces Successful Development of Tilapia Cell Line
-
A+ Charter Schools, Inc. Selects Varsity Tutors for Schools to Provide Students With Additional Learning Resources
-
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
-
Notice of Release of Barrick’s First Quarter 2024 Results
-
Announcement of AGM Results
-
Brightline West Awards Atlas Engineering and Design Contract
-
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
Builders FirstSource to Host First Quarter 2024 Financial Results Conference Call and Webcast
-
ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS

